-
Entrada Therapeutics (NASDAQ:TRDA) Receives "Buy" Rating from HC Wainwright
ソース: Buzz FX / 04 2 2025 08:32:09 America/New_York
Entrada Therapeutics (NASDAQ:TRDA) Receives "Buy" Rating from HC Wainwright Written by MarketBeat February 4, 2025 Share Link copied to clipboard. Entrada Therapeutics ( NASDAQ:TRDA - Get Free Report ) 's stock had its "buy" rating reaffirm
Read more...